Nautilus Biotechnology, Inc. Q1 Sales Decline

Nautilus Biotechnology, Inc. (NAUT) released earnings for first quarter of $0.593 million

The company's bottom line came in at $0.593 million, or $0.18 per share. This compares with $0.597 million, or $0.18 per share, last year.

The company's revenue for the period fell 1.0% to $4.13 million from $4.17 million last year.

Nautilus Biotechnology, Inc. earnings at a glance (GAAP) :

-Earnings: $0.593 Mln. vs. $0.597 Mln. last year.
-EPS: $0.18 vs. $0.18 last year.
-Revenue: $4.13 Mln vs. $4.17 Mln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com